Methode Ele Financials
This page shows Methode Ele (MEI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Methode Ele has an operating margin of -2.3%, meaning the company retains $-2 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -10.1% the prior year.
Methode Ele's revenue declined 6% year-over-year, from $1.1B to $1.0B. This contraction results in a growth score of 12/100.
Methode Ele carries a low D/E ratio of 0.47, meaning only $0.47 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 94/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 2.50, Methode Ele holds $2.50 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 80/100.
While Methode Ele generated $26.4M in operating cash flow, capex of $41.6M consumed most of it, leaving -$15.2M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Methode Ele passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Methode Ele generates $-0.42 in operating cash flow ($26.4M OCF vs -$62.6M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Methode Ele earns $-1.1 in operating income for every $1 of interest expense (-$23.9M vs $22.0M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Methode Ele generated $1.0B in revenue in fiscal year 2025. This represents a decrease of 6.0% from the prior year.
Methode Ele's EBITDA was $34.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 164.0% from the prior year.
Methode Ele generated -$15.2M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 463.0% from the prior year.
Methode Ele reported -$62.6M in net income in fiscal year 2025. This represents an increase of 49.2% from the prior year.
Methode Ele earned $-1.77 per diluted share (EPS) in fiscal year 2025. This represents an increase of 49.1% from the prior year.
Methode Ele held $121.1M in cash against $323.2M in long-term debt as of fiscal year 2025.
Methode Ele paid $0.56 per share in dividends in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Methode Ele had 35M shares outstanding in fiscal year 2025. This represents a decrease of 0.3% from the prior year.
Methode Ele's gross margin was 15.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.4 percentage points from the prior year.
Methode Ele's operating margin was -2.3% in fiscal year 2025, reflecting core business profitability. This is up 7.8 percentage points from the prior year.
Methode Ele's net profit margin was -6.0% in fiscal year 2025, showing the share of revenue converted to profit. This is up 5.1 percentage points from the prior year.
Methode Ele invested $41.8M in research and development in fiscal year 2025. This represents a decrease of 14.9% from the prior year.
Methode Ele spent $1.6M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 88.3% from the prior year.
Methode Ele invested $41.6M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 17.1% from the prior year.
MEI Income Statement
| Metric | Q2'26 | Q1'26 | Q3'25 | Q1'24 | Q2'25 | Q1'25 | Q1'23 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $246.9M+2.7% | $240.5M+0.3% | $239.9M | N/A | $288.0M-0.6% | $289.7M+2.6% | $282.4M+0.8% | $280.1M |
| Cost of Revenue | $199.2M+1.1% | $197.0M-0.8% | $198.6M | N/A | $235.7M0.0% | $235.7M+6.8% | $220.6M+2.5% | $215.2M |
| Gross Profit | $47.7M+9.7% | $43.5M+5.3% | $41.3M | N/A | $52.3M-3.1% | $54.0M-12.6% | $61.8M-4.8% | $64.9M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $39.0M+6.6% | $36.6M-2.9% | $37.7M | N/A | $40.9M-8.1% | $44.5M+26.1% | $35.3M+7.3% | $32.9M |
| Operating Income | $2.9M+163.6% | $1.1M+150.0% | -$2.2M | N/A | -$51.3M-1450.0% | $3.8M-82.6% | $21.8M-20.1% | $27.3M |
| Interest Expense | -$5.7M+3.4% | -$5.9M-7.3% | -$5.5M | N/A | -$4.4M-57.1% | -$2.8M | $0+100.0% | -$800K |
| Income Tax | $5.7M+35.7% | $4.2M-32.3% | $6.2M | N/A | -$200K-300.0% | $100K-97.7% | $4.4M+41.9% | $3.1M |
| Net Income | -$9.9M+3.9% | -$10.3M+28.5% | -$14.4M | N/A | -$55.3M-6244.4% | $900K-95.8% | $21.5M+8.0% | $19.9M |
| EPS (Diluted) | $-0.28+3.4% | $-0.29+29.3% | $-0.41 | N/A | $-1.55-7850.0% | $0.02-96.6% | $0.58+7.4% | $0.54 |
MEI Balance Sheet
| Metric | Q2'26 | Q1'26 | Q3'25 | Q1'24 | Q2'25 | Q1'25 | Q1'23 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.3B-0.3% | $1.3B-1.0% | $1.3B-7.0% | $1.4B-5.5% | $1.5B-5.7% | $1.6B-0.3% | $1.6B+10.5% | $1.4B |
| Current Assets | $555.3M+1.1% | $549.2M-4.0% | $572.2M-10.3% | $637.7M+0.2% | $636.5M-3.2% | $657.5M-1.0% | $664.4M-1.0% | $671.0M |
| Cash & Equivalents | $118.5M-2.1% | $121.1M+16.7% | $103.8M-35.7% | $161.5M+31.8% | $122.5M-17.2% | $147.9M-5.8% | $157.0M-4.7% | $164.7M |
| Inventory | $190.2M-0.4% | $190.9M-12.8% | $218.8M+17.5% | $186.2M+1.3% | $183.9M-16.4% | $219.9M+37.7% | $159.7M-9.0% | $175.4M |
| Accounts Receivable | $229.6M+6.5% | $215.6M-2.0% | $220.0M-16.2% | $262.6M-10.2% | $292.3M-2.8% | $300.8M-4.3% | $314.3M+6.4% | $295.5M |
| Goodwill | $173.4M-0.3% | $173.9M+3.9% | $167.4M-1.5% | $169.9M-23.0% | $220.7M-27.0% | $302.5M+0.2% | $301.9M+29.8% | $232.5M |
| Total Liabilities | $608.1M+0.8% | $603.2M+0.5% | $600.3M-5.8% | $637.5M-0.4% | $640.0M-0.3% | $641.8M+2.5% | $626.2M+28.9% | $485.9M |
| Current Liabilities | $217.6M-0.9% | $219.6M+9.0% | $201.4M-13.0% | $231.4M+6.0% | $218.3M+4.8% | $208.4M-8.6% | $228.0M+19.4% | $190.9M |
| Long-Term Debt | $332.3M+2.8% | $323.2M-1.4% | $327.7M-0.9% | $330.7M+0.5% | $329.0M-2.0% | $335.8M+10.6% | $303.6M+51.2% | $200.8M |
| Total Equity | $679.3M-1.3% | $688.1M-2.3% | $704.3M-8.1% | $766.0M-9.3% | $844.9M-9.3% | $931.4M-1.1% | $941.8M-0.1% | $942.6M |
| Retained Earnings | $498.9M-2.4% | $511.0M-8.5% | $558.3M-8.8% | $612.3M-12.2% | $697.0M-8.9% | $764.8M-1.0% | $772.7M-0.7% | $778.2M |
MEI Cash Flow Statement
| Metric | Q2'26 | Q1'26 | Q3'25 | Q1'24 | Q2'25 | Q1'25 | Q1'23 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$7.4M-129.5% | $25.1M-10.7% | $28.1M+12.9% | $24.9M+4250.0% | -$600K+89.3% | -$5.6M-111.4% | $49.0M-12.0% | $55.7M |
| Capital Expenditures | $4.2M-40.8% | $7.1M-16.5% | $8.5M-6.6% | $9.1M-15.0% | $10.7M-22.5% | $13.8M+23.2% | $11.2M-12.5% | $12.8M |
| Free Cash Flow | -$11.6M-164.4% | $18.0M-8.2% | $19.6M+24.1% | $15.8M+239.8% | -$11.3M+41.8% | -$19.4M-151.3% | $37.8M-11.9% | $42.9M |
| Investing Cash Flow | -$3.7M+36.2% | -$5.8M-1.8% | -$5.7M-126.5% | $21.5M+352.9% | -$8.5M+38.4% | -$13.8M+89.0% | -$125.8M-882.8% | -$12.8M |
| Financing Cash Flow | $7.6M+268.9% | -$4.5M+47.1% | -$8.5M-117.9% | -$3.9M+63.2% | -$10.6M-184.8% | $12.5M-81.3% | $66.8M+548.3% | -$14.9M |
| Dividends Paid | $1.9M-32.1% | $2.8M-47.2% | $5.3M+8.2% | $4.9M+2.1% | $4.8M-9.4% | $5.3M+8.2% | $4.9M-2.0% | $5.0M |
| Share Buybacks | $0 | $0 | $0-100.0% | $2.9M | N/A | N/A | $8.5M+6.3% | $8.0M |
MEI Financial Ratios
| Metric | Q2'26 | Q1'26 | Q3'25 | Q1'24 | Q2'25 | Q1'25 | Q1'23 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 19.3%+1.2pp | 18.1%+0.9pp | 17.2% | N/A | 18.2%-0.5pp | 18.6%-3.2pp | 21.9%-1.3pp | 23.2% |
| Operating Margin | 1.2%+0.7pp | 0.5%+1.4pp | -0.9% | N/A | -17.8%-19.1pp | 1.3%-6.4pp | 7.7%-2.0pp | 9.8% |
| Net Margin | -4.0%+0.3pp | -4.3%+1.7pp | -6.0% | N/A | -19.2%-19.5pp | 0.3%-7.3pp | 7.6%+0.5pp | 7.1% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | 0.1%-2.3pp | 2.4%+0.2pp | 2.1% |
| Return on Assets | -0.8%+0.0pp | -0.8%+0.3pp | -1.1% | N/A | -3.7%-3.8pp | 0.1%-1.5pp | 1.6%+0.2pp | 1.4% |
| Current Ratio | 2.55+0.1 | 2.50-0.3 | 2.84+0.1 | 2.76-0.2 | 2.92-0.2 | 3.15+0.2 | 2.91-0.6 | 3.51 |
| Debt-to-Equity | 0.49+0.0 | 0.470.0 | 0.47+0.0 | 0.43+0.0 | 0.39+0.0 | 0.36+0.0 | 0.32+0.1 | 0.21 |
| FCF Margin | -4.7%-12.2pp | 7.5%-0.7pp | 8.2% | N/A | -3.9%+2.8pp | -6.7%-7.8pp | 1.1%-14.2pp | 15.3% |
Similar Companies
Frequently Asked Questions
What is Methode Ele's annual revenue?
Methode Ele (MEI) reported $1.0B in total revenue for fiscal year 2025. This represents a -6.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Methode Ele's revenue growing?
Methode Ele (MEI) revenue declined by 6% year-over-year, from $1.1B to $1.0B in fiscal year 2025.
Is Methode Ele profitable?
No, Methode Ele (MEI) reported a net income of -$62.6M in fiscal year 2025, with a net profit margin of -6.0%.
What is Methode Ele's earnings per share (EPS)?
Methode Ele (MEI) reported diluted earnings per share of $-1.77 for fiscal year 2025. This represents a 49.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Methode Ele's EBITDA?
Methode Ele (MEI) had EBITDA of $34.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Methode Ele have?
As of fiscal year 2025, Methode Ele (MEI) had $121.1M in cash and equivalents against $323.2M in long-term debt.
What is Methode Ele's gross margin?
Methode Ele (MEI) had a gross margin of 15.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Methode Ele's operating margin?
Methode Ele (MEI) had an operating margin of -2.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Methode Ele's net profit margin?
Methode Ele (MEI) had a net profit margin of -6.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Methode Ele pay dividends?
Yes, Methode Ele (MEI) paid $0.56 per share in dividends during fiscal year 2025.
What is Methode Ele's free cash flow?
Methode Ele (MEI) generated -$15.2M in free cash flow during fiscal year 2025. This represents a -463.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Methode Ele's operating cash flow?
Methode Ele (MEI) generated $26.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Methode Ele's total assets?
Methode Ele (MEI) had $1.3B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Methode Ele's capital expenditures?
Methode Ele (MEI) invested $41.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Methode Ele spend on research and development?
Methode Ele (MEI) invested $41.8M in research and development during fiscal year 2025.
Does Methode Ele buy back shares?
Yes, Methode Ele (MEI) spent $1.6M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
How many shares does Methode Ele have outstanding?
Methode Ele (MEI) had 35M shares outstanding as of fiscal year 2025.
What is Methode Ele's current ratio?
Methode Ele (MEI) had a current ratio of 2.50 as of fiscal year 2025, which is generally considered healthy.
What is Methode Ele's debt-to-equity ratio?
Methode Ele (MEI) had a debt-to-equity ratio of 0.47 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Methode Ele's return on assets (ROA)?
Methode Ele (MEI) had a return on assets of -4.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Methode Ele's Piotroski F-Score?
Methode Ele (MEI) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Methode Ele's earnings high quality?
Methode Ele (MEI) has an earnings quality ratio of -0.42x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Methode Ele cover its interest payments?
Methode Ele (MEI) has an interest coverage ratio of -1.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Methode Ele?
Methode Ele (MEI) scores 37 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.